Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Craig

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2019
Reply to J. Wang et alDavid M Kurtz, Florian Scherer, Michael C Jin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2018
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell LymphomaDavid M Kurtz, Florian Scherer, Michael C Jin, et al.
Nature Biotechnology|July 23, 2021
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNADavid M Kurtz, Joanne Soo, Lyron Co Ting Keh, et al.
Cancer Cell|December 30, 2022
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomasBrian J Sworder, David M Kurtz, Stefan K Alig, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2019
Reply to J. Wang et alDavid M Kurtz, Florian Scherer, Michael C Jin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2018
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell LymphomaDavid M Kurtz, Florian Scherer, Michael C Jin, et al.
Nature Biotechnology|July 23, 2021
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNADavid M Kurtz, Joanne Soo, Lyron Co Ting Keh, et al.
Cancer Cell|December 30, 2022
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomasBrian J Sworder, David M Kurtz, Stefan K Alig, et al.
Pageof 2